Landscape Capital Management L.L.C. Invests $1.02 Million in Envista Holdings Corporation $NVST

Landscape Capital Management L.L.C. bought a new position in shares of Envista Holdings Corporation (NYSE:NVST) in the second quarter, Holdings Channel.com reports. The fund bought 38,610 shares of the company’s stock, valued at approximately $1,017,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Parallel Advisors LLC boosted its position in Envista by 13.1% during the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after acquiring an additional 367 shares during the last quarter. Bank of Montreal Can raised its position in shares of Envista by 1.4% in the 4th quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after acquiring an additional 372 shares in the last quarter. Sepio Capital LP raised its position in shares of Envista by 1.2% in the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after acquiring an additional 374 shares in the last quarter. Deutsche Bank AG raised its position in shares of Envista by 2.9% in the 4th quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after acquiring an additional 484 shares in the last quarter. Finally, State of Michigan Retirement System lifted its stake in shares of Envista by 1.5% in the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock valued at $1,001,000 after purchasing an additional 600 shares during the period.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on NVST shares. Evercore restated an “outperform” rating and set a $33.00 target price on shares of Envista in a research report on Thursday, May 7th. Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Morgan Stanley set a $23.00 price target on Envista in a research note on Thursday, August 6th. Barclays cut their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Finally, Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Envista presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Trading Up 0.0%

Shares of Envista stock opened at $27.21 on Monday. The company has a market capitalization of $4.37 billion, a P/E ratio of 46.91, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86. The stock has a fifty day simple moving average of $26.90 and a 200 day simple moving average of $26.30. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. During the same period in the previous year, the firm earned $0.26 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, sell-side analysts anticipate that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.